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Abstract 
This theme issue provides a timely collection of studies on magnetic nanoparticle-based im-
aging, bio-sensing, therapy and/or their combinations. 
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Magnetic  nanoparticles  have  long  been  an  im-
portant class of biomaterials. Iron oxide nanoparticles, 
for instance, have been used in the clinic as MR con-
trast  probes,  mostly  for  improving  the  visibility  of 
lesions in the reticuloendothelial system (RES) organs, 
such as the liver and lymph nodes. Recently, a new set 
of chemistry has emerged, which allows one to pre-
pare nanoparticles with fine control over a wide range 
of  parameters,  including  size,  shape,  composition, 
magnetization, surface coating and surface charge, etc 
[1]. Such a transition did not only affect the applica-
tions  of  magnetic  nanoparticles,  but  also  opened 
many new avenues. The idea is to see the nanoparti-
cles as not merely tiny magnetic crystals but rather, 
platforms with large surface-to-volume ratio. By har-
nessing  the  well-developed  surface  chemistry,  one 
can load a wide range of functionalities onto the par-
ticle surface. These include biovectors--such as pep-
tides, antibodies or aptamers--which are able to guide 
the migration of nanoparticles in a living subject and 
to accumulate them preferentially in the areas of in-
terest, such as tumor. On top of that, the nanoplatform 
can be further loaded with imaging motifs or thera-
peutic agents, and as a consequence, to be upgraded 
to  multifunctional  nanogadgets  with  either  multi-
modal imaging capabilities or theranostic features.  
In detail, studies on magnetic nanoparticles are 
currently focused on the following subjects: 
  Preparation  of  novel  magnetic  nanoparticle 
formulas  with  unique  physical  and  surface 
properties. 
  Studies on the toxicity of magnetic nanoparticles. 
  In vitro detection of biomarkers that are of diag-
nostic  and  prognostic  values  using  magnetic 
nanoparticles as the tags. 
  Magnetic  nanoparticle-based  probes  for  cell 
tracking, MR imaging, and multimodal imaging. 
  Magnetic nanoparticles-based therapeutics, such 
as for hyperthermia, drug delivery and gene de-
livery. 
In  this  special  issue,  we  invite  scholars  from 
worldwide  to  comment  on  or  report  cutting-edge 
studies on the preceding topics. It starts with an in-
formative review written by Jon et al. on constructing 
magnetic  nanoparticle-based,  multifunctional 
theranostic systems [2]. This review discusses a broad 
spectrum of important topics in the field, including 
targeting strategies, conjugation techniques and sur-
face engineering means used to shield nanoparticles 
from mononuclear phagocytic system. Subsequent to 
this is another review article contributed by Zhen and 
Xie,  who  summarize  the  current  progress  of  using 
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manganese-containing nanoparticles as MRI contrast 
agents  [3].  Unlike  iron  oxide  nanoparticles  that  are 
mostly  used  as  T2  contrast  probes  by  causing  hy-
pointensities,  manganese  nanoparticles  induce  hy-
perintensities on T1-weighted maps and therefore, can 
be diagnostically more favorable. It is also possible to 
load  therapeutics  onto  these  manganese  nanoplat-
forms to upgrade them to theranostic agents. In addi-
tion  to  working  as  in vivo  imaging  contrast  probes, 
magnetic  nanoparticles  have  also  found  uses  in  in 
vitro biosensing. Here Shao et al. report their work on 
developing  diagnostic  magnetic  resonance  systems 
(DMR) to detect cellular biomarkers with high sensi-
tivity and efficiency [4]. The DMR system has been 
dramatically improved in the past decade, thanks to 
the emergence of new magnetic nanoparticle biosen-
sors,  bioconjugation  strategies,  and  highly  sensitive 
miniaturized NMR systems. The system now enables 
parallel and rapid measurements from small sample 
volumes  and  on  a  wide  range  of  targets,  including 
whole  cells,  proteins,  DNA/mRNA,  metabolites, 
drugs,  viruses  and  bacteria.  Subsequently,  we  have 
two research articles. The first one comes from Ho et 
al., who studied tumor targeting with an iron oxide 
nanoparticle-tumstatin  conjugate  in  a  novel 
three-dimensional tissue culture model closely mim-
icking the in vivo tumor microenvironment [5]. Such a 
spheroid was constructed with a leaky endothelium 
coating  and  a  glioma  tumor  mass  core.  The  results 
showed  that  the  tumstatin-iron  oxide  nanoparticle 
conjugates  could  penetrate  and  selectively  target  to 
endothelial cell coating. This spheroid platform may 
serve  as  an  economic  alternative  to  evaluate  parti-
cle-tumor  microenvironment  interaction.  In  the  se-
cond  research  article,  Li  et  al.  report  a  side-by-side 
comparison study on two types of iron oxide nano-
particles  [6],  i.e.  thermally  cross-linked  superpara-
magnetic iron oxide nanoparticles (TCL-SPION) and 
monocrystalline iron oxide nanoparticles (MION-47). 
In particular, they incubated these two types of na-
noparticles with murine macrophage cells RAW264.7 
and evaluated the impact of the particles on the se-
cretion of interlukin-6 (IL-6) and tumor necrosis fac-
tor-alpha (TNF-α), the production of nitric oxides, and 
the  mitochondrial  membrane  potentials.  While  no 
significant impact on cell viability and growth veloc-
ity was observed, it was found that the use of both 
kinds of nanoparticles led to increased secretion levels 
of IL-6 and TNF-α. In addition, MION-47 also led to 
the production of nitric oxides and more collapses of 
mitochondrial membrane potential.  After these two 
research articles, Huang et al. discuss on how to im-
prove  MRI  contrast  and  detection  with  engineered 
magnetic  nanoparticles  [7].  This  work  tries  to  shed 
some light on the relationship between the intrinsic 
parameters of magnetic nanoparticles (e.g. composi-
tion, size and surface properties as well as the degree 
of aggregation) and the MRI relaxivities that decide 
the  performance  of  particles  as  imaging/diagnostic 
agents. Also discussed in this work are newly devel-
oped  MRI  methods  which  are  able  to  improve  the 
detection and quantification of the engineered mag-
netic nanoparticles. Magnetic nanoparticles can also 
be combined with other imaging agents to arrive at 
multimodality  imaging  probes.  For  instance, 
MRI/PET [8], MRI/optical [9] and MRI/PET/optical 
[10] imaging probes have been reported previously. In 
this special issue, Cai et al. overview the progress of 
constructing  magnetic  microbubbles  [11].  Magnetic 
microbubbles  are  dual-modal  imaging  probes  with 
both MR and ultrasound imaging functionalities.  In 
addition, it is postulated that the embedded magnetic 
nanoparticles as well as other payloads can be deliv-
ered to desired regions and released in response to 
appropriate  ultrasound  exposure.  Last,  Zhao  et  al. 
report  a  study  on  iron  oxide  nanoparticle-mediated 
hyperthermia  for  the  treatment  of  head  and  neck 
cancer [12]. It was found that temperature in nano-
particle-dosed  tumor  increased  to  40  °C  ~  50  °C 
within  5  minutes  by  heating  with  an  alternating 
magnetic field (AMF). Such a temperature increase fit 
well with theoretical simulation results. Further his-
tology studies found that the heating-induced tumor 
cell death was mostly achieved through necrosis ra-
ther than apoptosis. 
In summary, the use of magnetic nanoparticles 
in diagnosis and therapy is by all means a research 
hotspot and has attracted much attention. In this spe-
cial issue, we have solicited 5 review articles and 3 
research  papers  from  experienced  scholars  in  the 
field, with an aim of bringing broad and up-to-date 
knowledge to the audience. It is our hope that this 
timely issue will benefit students and researchers who 
are interested in this topic. 
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